Followers | 63 |
Posts | 8502 |
Boards Moderated | 0 |
Alias Born | 01/10/2014 |
Monday, July 12, 2021 1:42:39 PM
A new challenger is stepping into the ring with an HIV treatment that not only controls the disease but also boosts the immune system, something none of the HIV drugs can claim. Enzolytics (ENZC) HIV therapy is called ITV-1, which has a solid safety profile and demonstrated efficacy in HIV.
So for now, Gilead is still heavily dependent on HIV, and Enzolytics is threatening the cornerstone of its business.
https://insiderfinancial.com/enzolytics-enzc-takes-on-hiv-heavyweight-gilead-sciences/181723/
I don't call people names or use vulgar language in Public or Private. Once you cuss and call someone names you lost the argument and also lost your class. You have nothing else left to defend your comment. Statements are my Opinion only. Do your own DD.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM